Dr Keating will not discuss or take questions in relation to the scheme of arrangement pursuant to which it is proposed that Pfizer Australia Holdings Pty Limited (a wholly-ownedsubsidiary of Pfizer Inc) will acquire all of the issued shares of ResApp or the scheme booklet announced to ASX on 18 July 2021 and dispatched to shareholders on 20 July 2021
Ann: Investor Conference Call Notification, page-3
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
